Overview
Adamed Pharma is a Polish pharmaceutical and biotechnology company with 40 years of experience, developing and providing high-quality medicinal products, including prescription and over-the-counter drugs, dietary supplements, dermocosmetics, and medical devices. The company focuses on addressing chronic diseases across various therapeutic areas and holds 256 patents in the pharmaceutical field. Its products are available in dozens of countries worldwide, with an extensive portfolio of approximately 900 items.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
10 1240 6292 1111 0011 2067 8667- 17 1240 6292 1111 0011 2068 1742
- 82 1240 6292 1111 0011 2068 8914
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $4.4M$4,429,343 |
Buildings and premises | $83.0M$82,972,639 |
MSiG notices
7 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| May 28, 2026 | Shareholders' meeting convened | |
| Sep 24, 2021 | Merger registered | |
| Jun 5, 2019 | Commercial Companies Code notice | |
| Jan 3, 2019 | Merger plan | |
| Dec 10, 2018 | Commercial Companies Code notice |
Public aid
39 public aid cases recorded, with a total value of $54,955,630.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 5, 2025 | Aid for research and development projects: industrial research | $1.0M$1,022,653 | Prezes Agencji Badań Medycznych | |
| Apr 29, 2025 | Aid for research and development projects: industrial research | $341.4K$341,408 | Prezes Agencji Badań Medycznych | |
| Apr 29, 2025 | Aid for research and development projects: experimental development | $294.1K$294,147 | Prezes Agencji Badań Medycznych |
European Funds
5 projects co-financed from European Funds recorded, with total EU co-financing of $5,487,068.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-01-02 | Opracowanie oraz wdrożenie innowacyjnego produktu leczniczego w postaci tabletki do rozgryzania i żucia zawierającej substancję przeciwpsychotyczną II generacji. | $2.2M$2,164,451 | Regionalny Program Operacyjny Województwa Łódzkiego na lata 2014-2020 | |
| 2020-01-01 | LabGears: opracowanie i wdrożenie aplikacji internetowej do zarządzania i analizy danych badawczo-rozwojowych | $321.1K$321,058 | Regionalny Program Operacyjny Województwa Łódzkiego na lata 2014-2020 | |
| 2019-06-01 | „Opracowanie i wdrożenie nowoczesnej postaci leku o łatwej aplikacji, hamującego łysienie androgenowe oraz stymulującego odrost włosów zarówno u kobiet, jak i u mężczyzn”. | $149.0K$148,986 | Regionalny Program Operacyjny Województwa Łódzkiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Public sector contracts
Adamed Pharma is the contractor in 4 public sector contracts, worth PLN 10.66k in total. They were signed with 4 public buyers.
| Public buyer | Value | |
|---|---|---|
| Uniwersytecki Szpital Kliniczny w Radomsku | PLN 6,503 | |
| Uniwersytet Mikołaja Kopernika w Toruniu | PLN 181.42 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lubartowie | PLN 813.98 | |
| Wojewódzki Szpital Specjalistyczny Nr 2 w Jastrzębiu-Zdroju | PLN 3,167 |
Trademarks
Adamed Pharma holds 443 active trademarks registered with the Polish Patent Office. 51 applications are pending. 72 marks have expired or were not registered. The first mark was filed in 1960.
| Mark | Protected until | |
|---|---|---|
| BROTRIM(word) | Jan 21, 2036 | |
| TIOTRIX(word) | Jan 21, 2036 | |
| ULTRIM(word) | Nov 13, 2035 | |
| INDAGLIM(word) | Nov 13, 2035 | |
| DUOTRIM(word) | Nov 13, 2035 |
Authorized Representatives
Manner of representation
Declarations of will on behalf of the company require the joint action of two members of the management board, or one member of the management board jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Adpharmasp. z o.o. | 13,506.21 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $780,704,907.94 | polpharma.pl | ||
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| BiotonS.A. | $72,911,351.08 | bioton.com |
Change history
| Date | Event | |
|---|---|---|
| 2018-07-02 | Address change (Szkolna 33, 95- 054, Ksawerów → Ul. Mariana Adamkiewicza 6a, 05-152, Pieńków) | |
| 2018-07-02 | Share capital change (938,100,000.00 PLN → 718,430,000.00 PLN) | |
| 2018-07-02 | Name change ("zakład Farmaceutyczny Adamed Pharma" → Adamed Pharma) | |
| 2011-08-26 | Share capital change (100,000.00 PLN → 938,100,000.00 PLN) | |
| 2009-10-06 | Share capital change (1,000,000.00 PLN → 100,000.00 PLN) |
FAQ
Last updated: 2026-07-28